AIMEE HUNT: Open Payments
NPI 1407250681 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $146 |
| SHIELD THERAPEUTICS INC | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Abbott Laboratories | 1 | $24 |
| Stimlabs LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: AUSTEDO XR, ACCRUFER, INVEGA SUSTENNA, FREESTYLE LIBRE 3, ALLACOR P, COBENFY, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
